相关实验视频
Updated: Jan 17, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
作为结核病严重程度的标志物,Xpert MTB/RIF®周期值;结核病治疗分层的影响
Daniel J Grint1, Jasvir Dhillon2, Philip D Butcher2
1Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
概括
新的结核病 (TB) 分类确定了可以从缩短四个月治疗中受益的患者. 这种方法有助于定制结核病治疗方案,以获得更好的患者结果.
科学领域:
- 结核病的研究研究.
- 临床试验分析临床试验分析
- 药物治疗优化药物治疗的优化
背景情况:
- 缩短四个月结核病 (TB) 治疗方案对大多数患者有效.
- 一部分结核病患者需要更长的治疗时间.
- 确定优化结核病治疗方案的患者至关重要.
研究的目的:
- 为了优化治疗,定义结核病 (TB) 现型分类.
- 分析RIFASHORT试验数据用于结核病表型分类.
- 根据疾病的程度和细菌负担对结核病患者进行分层.
主要方法:
- 来自RIFASHORT结核病治疗缩短非劣势性试验的数据分析.
- 基于Xpert MTB/RIF®半定量细菌负荷和胸部X射线发现的结核病表型分类的开发.
- 重新分析初级结果,使用协议定义的八个百分点的非劣质标准.
主要成果:
- 结合Xpert MTB/RIF®细菌负担和胸部X射线分级,有效地区分了结核病复发和非复发.
- 广泛的结核病表型 (高细菌负担,广泛的X射线参与) 占试验人群的四分之一,超过一半的结核病复发.
- 对于有限的结核病表型,实验四个月的1200毫克里芬素治疗方案与标准的六个月治疗方案相比没有劣势.
结论:
- 由此衍生的结核病表型分类确定了四分之三的RIFASHORT参与者适合为期四个月的1200毫克里法素治疗方案.
- 该分类成功地确定了那些缩短疗程与标准护理水平不逊色的患者.
- 根据疾病分层的瑞芬素基结核病治疗的第三阶段随机试验是合理的.
相关概念视频
Pulmonary Tuberculosis IV
478
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
478
Pulmonary Tuberculosis III
937
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
937
Pulmonary Tuberculosis V
540
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
540
Pulmonary Tuberculosis I
838
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
838
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K

